secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001558370-24-009642
Event type: leadership
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Board member Jack Bech Nielsen resigns for health reasons; subsidiary Zynerba renamed
--------------------------------------------------------------------------------

- Jack Bech Nielsen resigned from the Board effective June 27, 2024 due to health reasons; no disagreements with the company.
- Wholly owned subsidiary Zynerba Pharmaceuticals, Inc. renamed to Harmony Biosciences Management, Inc. effective July 1, 2024.
- No financial or operational impact disclosed from either event.
- Ticker: HRMY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000155837024009642/0001558370-24-009642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000155837024009642/hrmy-20240627x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer